PT2968139T - Plataforma de entrega tópica de microemulsão - Google Patents

Plataforma de entrega tópica de microemulsão

Info

Publication number
PT2968139T
PT2968139T PT147207864T PT14720786T PT2968139T PT 2968139 T PT2968139 T PT 2968139T PT 147207864 T PT147207864 T PT 147207864T PT 14720786 T PT14720786 T PT 14720786T PT 2968139 T PT2968139 T PT 2968139T
Authority
PT
Portugal
Prior art keywords
delivery platform
topical
microemulsion delivery
topical microemulsion
platform
Prior art date
Application number
PT147207864T
Other languages
English (en)
Portuguese (pt)
Inventor
A Wassel Ronald
George Mondalek Fadee
A Farjo Rafal
B Quiambao Alexander
J Nuno Didier
Original Assignee
Eyecro Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eyecro Llc filed Critical Eyecro Llc
Publication of PT2968139T publication Critical patent/PT2968139T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT147207864T 2013-03-14 2014-03-13 Plataforma de entrega tópica de microemulsão PT2968139T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361784005P 2013-03-14 2013-03-14

Publications (1)

Publication Number Publication Date
PT2968139T true PT2968139T (pt) 2018-06-18

Family

ID=50628949

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147207864T PT2968139T (pt) 2013-03-14 2014-03-13 Plataforma de entrega tópica de microemulsão

Country Status (12)

Country Link
US (2) US8968775B2 (enExample)
EP (1) EP2968139B1 (enExample)
JP (1) JP6348567B2 (enExample)
CN (1) CN105451718B (enExample)
AU (1) AU2014244154B2 (enExample)
CA (1) CA2905023C (enExample)
DK (1) DK2968139T3 (enExample)
ES (1) ES2673009T3 (enExample)
PL (1) PL2968139T3 (enExample)
PT (1) PT2968139T (enExample)
TR (1) TR201808197T4 (enExample)
WO (1) WO2014160079A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2448494T3 (es) 2006-07-13 2014-03-14 Achillion Pharmaceuticals, Inc. Péptidos de 4-amino-4-oxobutanoilo en calidad de inhibidores de la replicación viral
ES2584534B1 (es) * 2015-03-27 2017-03-13 Retinset, S.L. Formulación tópica oftálmica de bosentan
WO2017127306A1 (en) 2016-01-18 2017-07-27 Arisan Therapeutics Adamatane derivatives for the treatment of filovirus infection
DK3266446T3 (en) * 2016-07-07 2019-02-11 Salvat Lab Sa Eye preparation comprising castor oil and medium chain triglyceride
US11548893B2 (en) 2017-07-15 2023-01-10 Arisan Therapeutics Inc. Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection
KR102652605B1 (ko) * 2017-08-27 2024-03-28 로드스 테크놀로지즈 안과 질환 치료를 위한 약학제적 조성물
US11583497B2 (en) 2017-11-14 2023-02-21 The Schepens Eye Research Institute, Inc. Nano-emulsion of CBFß-RUNX1 inhibitor for ocular drug delivery
JP7569336B2 (ja) 2019-06-11 2024-10-17 サイファイ エス.ピー.エー. マイクロエマルション組成物
JP6622950B1 (ja) * 2019-07-08 2019-12-18 株式会社Moresco マイクロエマルションを調製するための組成物、マイクロエマルション、これらの製造方法、及びマイクロエマルションの利用
JP7785295B2 (ja) * 2020-11-19 2025-12-15 学校法人日本大学 網膜循環障害及び網膜神経血管連関障害の改善用又は予防用点眼剤
US20240408010A1 (en) * 2021-10-01 2024-12-12 University Of South Africa A Nano Emulsified Phyto-Drug For Transdermal Treatment of Diabetes
WO2025034554A1 (en) * 2023-08-04 2025-02-13 Ads Therapeutics Llc Compositions and methods for delivery of ophthalmological actives
IL327899A (en) 2023-10-23 2026-06-01 Inmed Pharmaceuticals Inc Compositions and methods for use of cannabinol compounds in neuroprotection
WO2026085060A1 (en) * 2024-10-15 2026-04-23 Virginia Commonwealth University Ppara agonist loaded microemulsion and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI398261B (zh) * 2003-12-17 2013-06-11 Alcon Inc 血清類澱粉a基因於診斷及治療青光眼及鑑定抗青光眼劑上之用途
US7569612B1 (en) * 2006-08-21 2009-08-04 Mutual Pharmaceutical Company, Inc. Methods of use of fenofibric acid
US20090082470A1 (en) * 2007-09-24 2009-03-26 Rafal Farjo Stat3 inhibiting compositions and methods
US8652443B2 (en) * 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
AU2012214146A1 (en) * 2011-02-11 2013-08-29 Psivida Us, Inc. Methods of treating macular edema using antiedema therapeutics
WO2013049621A1 (en) * 2011-09-29 2013-04-04 The Board Of Regents Of The University Of Oklahoma Ophthalmic compositions comprising ppar-alpha agonists and methods of production and use thereof

Also Published As

Publication number Publication date
EP2968139B1 (en) 2018-05-23
JP6348567B2 (ja) 2018-06-27
AU2014244154A1 (en) 2015-09-24
WO2014160079A1 (en) 2014-10-02
US9149453B2 (en) 2015-10-06
PL2968139T3 (pl) 2018-10-31
CN105451718A (zh) 2016-03-30
EP2968139A1 (en) 2016-01-20
US8968775B2 (en) 2015-03-03
CA2905023A1 (en) 2014-10-02
AU2014244154B2 (en) 2018-08-09
CN105451718B (zh) 2018-09-28
ES2673009T3 (es) 2018-06-19
DK2968139T3 (en) 2018-06-25
US20150164846A1 (en) 2015-06-18
JP2016512562A (ja) 2016-04-28
CA2905023C (en) 2019-10-15
US20140275263A1 (en) 2014-09-18
TR201808197T4 (tr) 2018-07-23

Similar Documents

Publication Publication Date Title
ME03442B (me) Stabilizovani rastvorljivi pre-fuzioni rsv f polipeptidi
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
EP2967244A4 (en) ISSUE CONTAINER
EP3750590C0 (en) THRESHOLD RELEASE ADMINISTRATION CAPSULE
EP2957162A4 (en) SELF-DRIVING LAWNMOWER
EP2989885A4 (en) HARVESTER
FI20135021L (fi) Hissi
EP2964120A4 (en) ILIAKALVERBINDER
PL2968139T3 (pl) Platforma miejscowego podania mikroemulsji
DK3038674T3 (da) Medikamentafgivelsesindretning
PT3055308T (pt) Resumo
PL2829168T5 (pl) Kosiarka
DK3044389T3 (da) Vinduespost-tværstykke-konstruktion
HRP20182072T1 (hr) Rastavljiva samosklopiva struktura
DK2887262T3 (da) Punktskyforenkling
EP3000600A4 (en) LAMINATE
DE112014004954T8 (de) Abgabesystem
DK3035886T3 (da) Inhalator
FI20135231A7 (fi) Potilasalusta
LT3035885T (lt) Inhaliatorius
DK2947323T3 (da) Spiralhuspumpe
DE112014004938T8 (de) Abgabesystem
LT3035887T (lt) Inhaliatorius
EP2969728C0 (en) HANDLE-POWERED VELOCIPEDE
DK2973500T3 (da) Bevægelsesplatformkonfiguration